Potential drug-drug interactions in patients presenting with osteoarthritis to community orthopaedic clinics of Abbottabad, Khyber Pakhtunkhwa: A cross-sectional study

Baxter, 2006 Walker, 2012 Shetty, 2018, Evaluation of potential drug-drug interactions with medications prescribed to geriatric patients in a tertiary care hospital, Age Res, 1 Dechanont, 2014, Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis, Pharmacoepidemiol Drug Saf, 23, 489, 10.1002/pds.3592 Yusuf, 2016, Pharmacologic and non-pharmacologic treatment of osteoarthritis, Curr Treat Options Rheumatol, 2, 111, 10.1007/s40674-016-0042-y Arden, 2006, Osteoarthritis: epidemiology, Best Prac Res Clin Rheum, 20, 3, 10.1016/j.berh.2005.09.007 Valdes, 2018, Osteoarthritis and ageing, Eur Med J, 3, 116, 10.33590/emj/10313855 Schmidt, 2018, Approach to osteoarthritis management for the primary care provider, Prim Care, 45, 61, 10.1016/j.pop.2018.02.009 Dobson, 2018, Defining the osteoarthritis patient: back to the future, Osteoarthritis Cartilage, 26, 1003, 10.1016/j.joca.2018.04.018 Khan, 2016, Prescribing pattern and drug-drug interactions of analgesics prescribed for pain management in a Pakistani tertiary hospital, J Appl Pharm, 8, 1 Korucu, 2018, A retrospective study on potential drug interactions: a single centre experience, J Oncol, 4, 80 Robertson, 2007 Ismail, 2018, Potential drug-drug interactions in outpatient department of a tertiary care hospital in Pakistan: a cross-sectional study, BMC Health Serv Res, 18, 1 Raosoft, 2019 Chemical classification of drugs. National library of medicines. https://pubchem.ncbi.nlm.nih.gov/. [Accessed: 22/08/2019]. World Health Organization. Anatomical, therapeutic, chemical classification. https://www.who.int/tools/atc-ddd-toolkit/atc-classification. [Accessed: 20/08/2019]. Medscape, 2019 IBM SPSS software. https://www.ibm.com/analytics/spss-statistics-software. [Accessed: 20/08/2019]. Watt, 2018, Osteoarthritis biomarkers: year in review, Osteoarthritis, 26, 312, 10.1016/j.joca.2017.10.016 Theile, 2007, Prevalence and predictors of polypharmacy among older primary care patients in Germany, Fam Pract, 24, 14 Fernandes, 2013, EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis, Ann Rheum Dis, 72, 1125, 10.1136/annrheumdis-2012-202745 Zhang, 2010, OARSI recommendations for the management of hip and knee osteoarthritis, Osteoarthritis, 18, 476, 10.1016/j.joca.2010.01.013 Shayam, 2016, Pattern of drug prescribing in osteoarthritis patients attending orthopaedic outpatient department of a tertiary care hospital, Drug Deliv Ther, 6, 14